Company Filing History:
Years Active: 2023-2024
Title: The Innovative Contributions of Ming-Shiu Lin
Introduction
Ming-Shiu Lin is a prominent inventor based in Taipei, Taiwan. He has made significant contributions to the field of medicinal chemistry, particularly in the development of compounds aimed at treating various types of cancer. With a total of 2 patents, his work focuses on innovative methods to combat proliferative diseases.
Latest Patents
Ming-Shiu Lin's latest patents include groundbreaking methods of using 4(1)-quinolone derivatives. These patents provide new compounds, compositions, and methods for treating, delaying, and preventing the adverse effects of proliferative diseases, such as lung cancer, breast cancer, ovarian cancer, prostate cancer, head and neck cancer, and leukemia. The disclosed methods involve inhibiting the polymerization of cancer cell microtubules, binding β-tubulin, and inducing apoptosis in cancer cells resistant to multiple drugs. Additionally, his patents cover pharmaceutical compositions, kits, and methods for utilizing these compounds in treating the aforementioned diseases.
Career Highlights
Ming-Shiu Lin is affiliated with Academia Sinica, a prestigious research institution in Taiwan. His work has garnered attention for its potential impact on cancer treatment, showcasing his dedication to advancing medical science through innovative research.
Collaborations
Ming-Shiu Lin has collaborated with notable colleagues, including Rong-Jie Chein and Pan-Chyr Yang. These partnerships have contributed to the development of his patents and the advancement of research in the field of cancer therapeutics.
Conclusion
Ming-Shiu Lin's innovative work in the field of medicinal chemistry highlights his commitment to addressing critical health challenges. His patents represent significant advancements in cancer treatment, showcasing the potential of 4(1)-quinolone derivatives in combating various forms of cancer.